Vascular miRNAs After Balloon Angioplasty

Trends in Cardiovascular Medicine

Volumn 23, Issue 1, 2013, Pages 9-

  Polimeni, Alberto ^a   De Rosa, Salvatore ^a   Indolfi, Ciro ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; UNTRANSLATED RNA;

BLOOD VESSEL INJURY; CARDIOVASCULAR FUNCTION; CELL INTERACTION; CELL PROLIFERATION; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; MOLECULAR INTERACTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHENOTYPE; PRIORITY JOURNAL; REGENERATION; REVIEW; STENT THROMBOSIS; TRANSLATION REGULATION; VASCULAR PATENCY; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; VASCULAR DISEASE;

ANGIOPLASTY, BALLOON; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; PHENOTYPE; VASCULAR DISEASES; VASCULAR SYSTEM INJURIES;

MLCS; MLOWN;

EID: 84879539951     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.08.004     Document Type: Review

References (44)

1. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
2. Boon R.A., Horrevoets A.J., et al. Key transcriptional regulators of the vasoprotective effects of shear stress. Hamostaseologie 2009, 29:39-40.
3. Casscells W. Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation 1992, 86:723-729.
4. Chan M.C., Hilyard A.C., Wu C., et al. Molecular basis for antagonism between PDGF and the TGFbeta family of signalling pathways by control of miR-24 expression. EMBO Journal 2010, 29:559-573.
5. Chatzizisis Y.S., Coskun A.U., Jonas M., et al. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. Journal of the American College of Cardiology 2007, 49:2379-2393.
6. Chen J., Yin H., Jiang Y., et al. Induction of microrna-1 by myocardin in smooth muscle cells inhibits cell proliferation. Arteriosclerosis, Thrombosis, and Vascular Biology 2010, 31:368-375.
7. Cheng Y., Liu X., Yang J., et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circulation Research 2009, 105:158-166.
8. Cordes K.R., Sheehy N.T., White M.P., et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
9. Curcio A., Torella D., Indolfi C. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. Circulation Journal 2011, 75:1287-1296.
10. Davis B.N., Hilyard A.C., Lagna G., et al. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008, 454:56-61.
11. De Rosa S., Fichtlscherer S., Lehmann R., et al. Transcoronary concentration gradients of circulating microRNAs. Circulation 2011, 124:1936-1944.
12. Elia L., Quintavalle M., Zhang J., et al. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death and Differentiation 2009, 16:1590-1598.
13. Fang Y., Shi C., Manduchi E., et al. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:13450-13455.
14. Fish J.E., Santoro M.M., Morton S.U., et al. miR-126 regulates angiogenic signaling and vascular integrity. Developmental Cell 2008, 15:272-284.
15. Harris T.A., Yamakuchi M., Ferlito M., et al. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:1516-1521.
16. Hergenreider E., Heydt S., Tréguer K., et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nature Cell Biology 2012, 14:249-256.
17. Iaconetti C., Polimeni A., Sorrentino S., et al. Inhibition of mir-92a increases endothelial proliferation and migration in vitro as well as reduces neointimal proliferation in vivo after vascular injury. Basic Research in Cardiology 2012, 107:296-309.
18. Indolfi C., Esposito G., Di Lorenzo E., et al. Smooth muscle cell proliferation is proportional to the degree of balloon injury in a rat model of angioplasty. Circulation 1995, 92:1230-1235.
19. Indolfi C., Avvedimento E.V., Rapacciuolo A., et al. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nature Medicine 1995, 1:541-545.
20. Indolfi C., Avvedimento E.V., Di Lorenzo E., et al. Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury. Nature Medicine 1997, 3:775-779.
21. Indolfi C., Di Lorenzo E., Rapacciuolo A., et al. 8-Chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo. Journal of the American College of Cardiology 2000, 36:288-293.
22. Indolfi C., Torella D., Cavuto L., et al. Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats. Circulation 2001, 103:2980-2986.
23. Indolfi C., Stabile E., Coppola C., et al. Membrane-bound protein kinase A inhibits smooth muscle cell proliferation in vitro and in vivo by amplifying cAMP-protein kinase A signals. Circulation Research 2001, 88:319-324.
24. Indolfi C., Torella D., Coppola C., et al. Physical training increases eNOS vascular expression and activity and reduces restenosis after balloon angioplasty or arterial stenting in rats. Circulation Research 2002, 91(13):1190-1197.
25. Indolfi C., Mongiardo A., Curcio A., et al. Molecular mechanisms of in-stent restenosis and approach to therapy with eluting stents. Trends in Cardiovascular Medicine 2003, 13:142-148.
26. Indolfi C., Pavia M., Angelillo I.F., et al. Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis). American Journal of Cardiology 2005, 95:1146-1152.
27. Ji R., Cheng Y., Yue J., et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circulation Research 2007, 100:1579-1588.
28. Leeper N.J., Raiesdana A., Kojima Y., et al. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. Journal of Cellular Physiology 2011, 226:1035-1043.
29. Liu X., Cheng Y., Chen X., et al. MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2. Journal of Biological Chemistry 2011, 286:42371-42380.
30. Liu X., Cheng Y., Yang J., et al. Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application. Journal of Molecular and Cellular Cardiology 2012, 52:245-255.
31. Lu D., Kassab G.S., et al. Role of shear stress and stretch in vascular mechanobiology. Journal of the Royal Society Interface 2011, 8:1379-1385.
32. Menghini R., Casagrande V., Cardellini M., et al. MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 2009, 120:1524-1532.
33. Minami Y., Satoh M., Maesawa C., et al. Effect of atorvastatin on microRNA 221/222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. European Journal of Clinical Investigation 2009, 39:359-367.
34. Ni C.W., Qiu H., Jo H., et al. MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells. American Journal of Physiology: Heart and Circulatory Physiology 2011, 300:1762-1769.
35. Nicoli S., Standley C., Walker P., et al. MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature 2010, 464:1196-1200.
36. Qin X., Wang X., Wang Y., et al. MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:3240-3244.
37. Sun S.G., Zheng B., Han M., et al. miR-146a and Krüppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Reports 2011, 12:56-62.
38. Thum T. MicroRNA therapeutics in cardiovascular medicine. EMBO Molecular Medicine 2012, 4:3-14.
39. Torella D., Iaconetti C., Catalucci D., et al. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circulation Research 2011, 109:880-893.
40. Wu W., Xiao H., Laguna-Fernandez A., et al. Flow-dependent regulation of Kruppel-like factor 2 is mediated by microrna-92a. Circulation 2011, 124:633-641.
41. Xie C., Huang H., Sun X., et al. MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor 4. Stem Cells and Development 2011, 20:205-210.
42. Zampetaki A., Willeit P., Drozdov I., et al. Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovascular Research 2012, 93:555-562.
43. Zernecke A., Bidzhekov K., Noels H., et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Science Signaling 2009, 2:ra81.
44. Zhang Y., Liu D., Chen X., et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Molecular Cell 2010, 39:133-144.